Journal article · 2022
In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy
ACS Nano, 16(9), 15226–15236 · Published 26 August 2022 · DOI 10.1021/acsnano.2c06560
In brief
“In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy” is a 2022 journal article by Liangjie Jin and 8 co-authors, published in ACS Nano. OpenAlex counts 49 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 49
- Most cited in
- 2024 (22)
- Field-weighted impact
- 3.59
- References
- 53
- Authors
- 9
Abstract
In situ cancer vaccines consisting of antigens and adjuvants are a promising cancer treatment modality; however, the convenient manufacture of vaccines in vivo and their efficient delivery to lymph nodes (LNs) remains a major challenge. Herein, we outline a facile approach to simultaneously achieve the in situ programming of vaccines via two synergetic nanomedicines, Tu-NP… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Jin, L., Yang, D., Song, Y., Li, D., Xu, W., Zhu, Y., Xu, C., Lü, Y., & Yang, X. (2022). In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy. ACS Nano, 16(9), 15226–15236. https://doi.org/10.1021/acsnano.2c06560
MLA 9
Jin, Liangjie, et al. “In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy.” ACS Nano, vol. 16, no. 9, 2022, pp. 15226–15236. https://doi.org/10.1021/acsnano.2c06560.
Chicago
Jin, Liangjie, Dongmei Yang, Yonghong Song, Dongdong Li, Weijia Xu, Yueqiang Zhu, Cong‐Fei Xu, Yang Lü, and Xianzhu Yang. 2022. “In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy.” ACS Nano 16 (9): 15226–15236. https://doi.org/10.1021/acsnano.2c06560.
Harvard
Jin, L. et al. (2022) ‘In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy’, ACS Nano, 16(9), pp. 15226–15236. doi:10.1021/acsnano.2c06560.
IEEE
L. Jin et al., “In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy,” ACS Nano, vol. 16, no. 9, pp. 15226–15236, 2022, doi: 10.1021/acsnano.2c06560.
BibTeX
@article{jin2022situ,
title = {{In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy}},
author = {Jin, Liangjie and Yang, Dongmei and Song, Yonghong and Li, Dongdong and Xu, Weijia and Zhu, Yueqiang and Xu, Cong‐Fei and Lü, Yang and Yang, Xianzhu},
journal = {ACS Nano},
year = {2022},
volume = {16},
number = {9},
pages = {15226--15236},
doi = {10.1021/acsnano.2c06560},
url = {https://doi.org/10.1021/acsnano.2c06560}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 1 | |
| 2023 | 6 | |
| 2024 | 22 | |
| 2025 | 13 | |
| 2026 | 7 |
Its field-weighted citation impact is 3.59: it has been cited 3.59 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- nanovaccines
- alternating magnetic field
- magnetic nanoparticles
- R848
- adjuvants
- dendritic cell maturation
- CTLA-4 blockade
- cancer immunotherapy
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Jin, L., Yang, D., Song, Y., Li, D., Xu, W., Zhu, Y., Xu, C., Lü, Y., & Yang, X. (2022). In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy. ACS Nano, 16(9), 15226–15236. https://doi.org/10.1021/acsnano.2c06560
How many times has this paper been cited?
49 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Liangjie Jin, Dongmei Yang, Yonghong Song, Dongdong Li, Weijia Xu, Yueqiang Zhu, Cong‐Fei Xu, Yang Lü, Xianzhu Yang.
What is the DOI of this paper?
10.1021/acsnano.2c06560, permanently at https://doi.org/10.1021/acsnano.2c06560. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.